ARQT vs CPT · rev $235.3M vs P/E 104, rev $5.3M
Arcutis Biotherapeutics Inc (ARQT) versus Camden Property Trust (CPT) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Latest reported ARQT revenue for 2026-06-30 was $235.3M. Net income was $3.7M. ARQT currently screens at market cap $1.64B.
Latest reported CPT revenue for 2026-06-30 was $5.3M. Net income was $61.2M. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
ARQT currently screens at market cap $1.64B. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Not investment advice. Open the ARQT and CPT stock pages for the full models.
Not investment advice.